Cure Multiple Myeloma Corporation

Analysis

Cure Multiple Myeloma Corporation is a registered charity in United States, based in Novi, MI. It received its IRS tax-exemption ruling in October 2015, 11 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Cure Multiple Myeloma Corporation reported income of $215k and spending of $295k, spending 137% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $188k to $215k (+14%), an average of +3.4% a year. The sharpest change came in the year to December 2021, when income rose by 75%. Over the whole period it spent 99% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Cure Multiple Myeloma Corporation sits at the 42nd percentile: it is larger than about 42% of them. Against every charity in United States with reported income it ranks in the 55th percentile, and in the 55th percentile within MI. Charities of a similar size with the same main cause include American Citizens for Health Choice ($215k), South Dakota Parkinson Foundation ($215k) and Gcos a Helping Hand Foundation ($215k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 100% of the total. It paid $41k in professional fundraising fees. At year end it held assets of $28k against liabilities of $0, net assets of $28k.